Purespring Therapeutics
PrivateLast Round
Series B
Oct 9, 2024
Est. Valuation
$74.5M
Total Funding Raised
$167.58M
Company Overview
Purespring Therapeutics is a biotechnology company that develops AAV gene therapies to treat kidney diseases by targeting the podocyte.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Purespring Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Purespring Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Oct 9, 2024 | ||||
| Series A | Jul 30, 2021 |
Key People
Founding team and executive leadership
Purespring Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Syncona | Series A |
| British Patient Capital | Series B |
| Gilde Healthcare | Series B |
| Sofinnova Partners | Series B |
| Syncona Limited | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 25, 2025
Team to present at Piper Sandler's 37th Annual Healthcare Conference in December.
- Nov 4, 2025
Product candidate PS-002 enters Phase I/II trial for IgA nephropathy.
Purespring Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Purespring Therapeutics's valuation, stock price, and market status.
